Table 1 Demographic and clinical characteristics of 283 patients starting a low IFNB dose.
| Â | Patients switching to high IFNB dose n = 121 | Patients remaining on low IFNB dose n = 162 | Pooled n = 283 |
|---|---|---|---|
Male gender, n (%) | 39 (32.2) | 49 (30.2) | 88 (31.1) |
Age, years | 31.5 (8.5) | 32.8 (9.8) | 32.2 (9.2) |
MS duration, years | 5.4 (5.3) | 6.1 (5.9) | 5.8 (5.7) |
Annualised relapse rate pre-IFNB | 1.00 (0.74) | 0.92 (0.76) | 0.95 (0.75) |
EDSS score, median [range] | 1.5 [0 - 3.5] | 1.5 [0 - 3.5] | 1.5 [0 - 3.5] |
Active MRI scan, n (%) | 65 (53.7) | 69 (42.6) | 134 (47.3) |